Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysis
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 85, Issue 1, Pages 160-168
Publisher
Wiley
Online
2018-10-08
DOI
10.1111/bcp.13782
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials
- (2018) Robert Puckrin et al. ACTA DIABETOLOGICA
- Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies
- (2017) Edward Chia-Cheng Lai et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2. Classification and Diagnosis of Diabetes
- (2016) DIABETES CARE
- Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials
- (2016) Dandan Li et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis
- (2016) F. Zaccardi et al. DIABETES OBESITY & METABOLISM
- Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
- (2016) Jason H Y Wu et al. Lancet Diabetes & Endocrinology
- Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2016) Heidi Storgaard et al. PLoS One
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study
- (2014) Nicole L Pratt et al. BMC Medical Research Methodology
- Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies
- (2014) Paul Nyirjesy et al. CURRENT MEDICAL RESEARCH AND OPINION
- Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes
- (2013) Despoina Vasilakou et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials
- (2013) M. Monami et al. DIABETES OBESITY & METABOLISM
- Angiotensin-Converting Enzyme Inhibitor Treatment and the Development of Urinary Tract Infections: A Prescription Sequence Symmetry Analysis
- (2013) Koen B. Pouwels et al. DRUG SAFETY
- Inhaled Corticosteroids and the Occurrence of Oral Candidiasis: A Prescription Sequence Symmetry Analysis
- (2013) Job F. M. van Boven et al. DRUG SAFETY
- The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection
- (2013) Izyan A. Wahab et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Genital Mycotic Infections in Patients With Diabetes
- (2013) Paul Nyirjesy et al. POSTGRADUATE MEDICINE
- Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis
- (2009) Ioannis Tsiropoulos et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started